Release Date: 24/01/19 12:16 Summary: Independent Valuation of Luapula Process Facility Underway Price Sensitive: No Download Document 418.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%